adam brufsky, md, phd: expectations of therapy in breast cancer
Published 8 years ago • 65 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
1:44
adam brufsky, md, phd: choices of therapy in breast cancer
-
1:04
adam brufsky, md, phd: expectations of therapy
-
0:49
adam brufsky, md, phd: considerations for different therapies in breast cancer
-
1:10
adam brufsky, md, phd: choices of therapy
-
5:31
goals of therapy in metastatic breast cancer
-
2:39
adam brufsky, md, phd, describes the treatment landscape of her2 metastatic breast cancer
-
3:21
adam brufsky, md, phd, considers the investigation of poziotinib in her2 metastatic breast cancer
-
4:05
an overview of immunotherapy in breast cancer - an interview with adam brufsky
-
1:06
dr. brufsky on challenges in breast cancer
-
2:47
adam brufsky, md, phd: clinical trial data supporting these choices
-
0:30
dr. brufsky on adjuvant bisphosphonates for patients with breast cancer
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
1:29
dr. brufsky on the colet trial for triple-negative breast cancer
-
1:19
dr adam brufsky: choosing a therapy for breast cancer patients
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
1:16
dr. brufsky advises doctors on bevacizumab for breast cancer
-
1:46
dr. brufsky discusses adjuvant bisphosphonates as a new standard of care
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
1:41
dr. brufsky on implementing pertuzumab in her2 breast cancer